Omega-3s: Heart health questions, depression and MS
As for omega-3s, the news was dominated by a high-profile study claiming there was insufficient evidence for a secondary preventive effect of omega-3 fatty acid supplements vs cardiovascular events among patients with a history of heart disease. However, it was immediately challenged by industry.
‘Insufficient’ evidence for omega-3 heart benefits, suggests meta-analysis
Another study argued that omega-3s had no benefit on the disease activity of multiple sclerosis, although the authors acknowledged their trial was underpowered. Omega-3 has no benefit for multiple sclerosis, finds 'underpowered' RCT
On a more positive note, a study from the University of Rochester, New York, suggested that increased intakes of EPA and DHA may be associated with a decrease in depressive symptoms.